Timing of correct parenteral antibiotic initiation and outcomes from severe bacterial community-acquired pneumonia in children

Pediatric Infectious Disease Journal

Volumn 30, Issue 4, 2011, Pages 295-301

  Muszynski, Jennifer A ^a   Knatz, Nina L ^b   Sargel, Cheryl L ^a   Fernandez, Soledad A ^c   Marquardt, David J ^a   Hall, Mark W ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Antibiotics; Empiric; Pediatric; Pneumonia; Timing

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; CHILD; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE; LENGTH OF STAY; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THERAPY DELAY; TREATMENT OUTCOME;

EID: 79954741766     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181ff64ec     Document Type: Article

References (27)

1. DeFrances CJ, Lucas CA, Buie VC, et al. 2006 National Hospital Discharge Survey. Natl Health Stat Report. 2008;5:1-20.
2. Minino AM, Heron MP, Murphy SL, et al. Deaths: final data for 2004. Natl Vital Stat Rep. 2007;55:1-119.
3. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, et al. Antimicrobial use and the influence of inadequate empiric antimicrobial therapy on the outcomes of nosocomial bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2004;25:735-741. (Pubitemid 39312044)
4. Krobot K, Yin D, Zhang Q, et al. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis. 2004;23:682-687. (Pubitemid 39304322)
5. Mueller EW, Hanes SD, Croce MA, et al. Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients. J Trauma. 2005;58:94-101.
6. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-1596. (Pubitemid 43810035)
7. Wood GC, Mueller EW, Croce MA, et al. Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period. Surg Infect (Larchmt). 2005;6:203-213. (Pubitemid 41388155)
8. Silber SH, Garrett C, Singh R, et al. Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia. Chest. 2003;124:1798-1804. (Pubitemid 37433575)
9. Bruns AH, Oosterheert JJ, Hustinx WN, et al. Time for first antibiotic dose is not predictive for the early clinical failure of moderate-severe community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. 2009;28:913-919.
10. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72. (Pubitemid 46290553)
11. Rudan I, Tomaskovic L, Boschi-Pinto C, et al. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ. 2004;82:895-903. (Pubitemid 40065157)
12. Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997. Pediatrics. 2000;106:205-209. (Pubitemid 30436857)
13. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 1996;24:743-752. (Pubitemid 26155716)
14. Leteurtre S, Martinot A, Duhamel A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet. 2003;362:192-197. (Pubitemid 36859934)
15. Thomas NJ, Shaffer ML, Willson DF, et al. Defining acute lung disease in children with the oxygenation saturation index. Pediatr Crit Care Med. 2010;11:12-17.
16. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003;37:1405-1433. (Pubitemid 37494668)
17. Pong A, Bradley JS. Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics. Semin Pediatr Infect Dis. 2004;15:21-29. (Pubitemid 38620275)
18. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997;278:2080-2084. (Pubitemid 28016230)
19. Houck PM, MacLehose RF, Niederman MS, et al. Empiric antibiotic therapy and mortality among Medicare pneumonia inpatients in 10 western states: 1993, 1995, and 1997. Chest. 2001;119:1420-1426. (Pubitemid 32686024)
20. Nazarian DJ, Eddy OL, Lukens TW, et al. Clinical policy: critical issues in the management of adult patients presenting to the emergency department with community-acquired pneumonia. Ann Emerg Med. 2009;54:704-731.
21. Berjohn CM, Fishman NO, Joffe MM, et al. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia. Medicine (Baltimore). 2008;87:160-166. (Pubitemid 351769911)
22. Sandora TJ, Desai R, Miko BA, et al. Assessing quality indicators for pediatric community-acquired pneumonia. Am J Med Qual. 2009;24:419-427.
23. Levin D, Tribuzio M, Green-Wrzesinki T, et al. Empiric antibiotics are justified for infants with respiratory syncytial virus lower respiratory tract infection presenting with respiratory failure: a prospective study and evidence review. Pediatr Crit Care Med. 2010;11:390-395.
24. Shorr AF, Owens RC Jr. Quality pneumonia care: distinguishing community-acquired from health care-associated pneumonia. Am J Health Syst Pharm. 2009;66(suppl 4):S8-S14.
25. Kollef MH, Napolitano LM, Solomkin JS, et al. Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit. Clin Infect Dis. 2008;47(suppl 2):S55-S99; quiz S100-S101.
26. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest. 2005;128:3854-3862. (Pubitemid 43062645)
27. Battleman DS, Callahan M, Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. Arch Intern Med. 2002;162:682-688. (Pubitemid 34226395)